An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Atara Biotherapeutics to Participate at Three Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Atara Biotherapeutics (Nasdaq: ATRA), a leader in T-cell immunotherapy, announced that CEO Pascal Touchon will participate in three virtual conferences. These include the Cowen 5th Annual IO Next Summit on November 15, 2021, at 9:45 a.m. EST, the Stifel 2021 Virtual Healthcare Conference, also on November 15, 2021, at 4:40 p.m. EST, and the Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021, at 10:05 a.m. EST. Live webcasts will be available on their website, with archived replays accessible for 30 days.
Positive
None.
Negative
None.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer of Atara, will participate at three upcoming virtual conferences.
Cowen 5th Annual IO Next Summit
Fireside chat on Monday, November 15, 2021 at 9:45 a.m. EST
Stifel 2021 Virtual Healthcare Conference Fireside chat on Monday, November 15, 2021 at 4:40 p.m. EST
Evercore ISI 4th Annual HealthCONx Virtual Conference Fireside chat on Tuesday, November 30, 2021 at 10:05 a.m. EST
Live video webcasts will be available by visiting the Investor Events and Presentations section of atarabio.com. Archived replays will be available on the Company's website for 30 days following the live webcasts.
About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program in Phase 3 clinical development, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel® in Phase 3 development for Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR T) immunotherapies for both solid tumors and hematologic malignancies. Improving patients’ lives is our mission and we will never stop working to bring transformative therapies to those in need. Atara is headquartered in South San Francisco and our leading-edge research, development and manufacturing facility is based in Thousand Oaks, California. For additional information about the company, please visit atarabio.com and follow us on Twitter and LinkedIn.
What conferences will Atara Biotherapeutics participate in November 2021?
Atara Biotherapeutics will participate in the Cowen 5th Annual IO Next Summit and the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, and the Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021.
Who is the CEO of Atara Biotherapeutics?
Pascal Touchon is the President and CEO of Atara Biotherapeutics.
When is the Cowen 5th Annual IO Next Summit?
The Cowen 5th Annual IO Next Summit is scheduled for November 15, 2021, at 9:45 a.m. EST.
What time is the Stifel 2021 Virtual Healthcare Conference?
The Stifel 2021 Virtual Healthcare Conference will take place on November 15, 2021, at 4:40 p.m. EST.
How can I access the live webcasts of Atara Biotherapeutics' conferences?
Live webcasts of Atara Biotherapeutics' conferences can be accessed through the Investor Events and Presentations section of their website.
